Global Research Report on Parkinson's Disease Market - 1 views
-
Matilde Fernandes on 24 Jan 14One of the main drivers propelling the growth of the market for drugs used to treat patients with Parkinson's disease is the steadily growing aging population worldwide. This is because the number of patients suffering from Parkinson's disease is increasing owing to the rise in aging population both in the developing as well as developed nations. One of the major challenges to market growth is the weak pipeline landscape. Most products in the pipeline lack molecules that can potentially achieve blockbuster status in the near future.